Clinical Laboratory costs account for less than 3% of the total healthcare cost yet it is estimated that 70% of medical decisions are influenced by these tests. These include diagnosis, prognosis and risk assessment, preventive and screening for illnesses and monitoring and management of treatment. In addition, aggregate test results data are used for public health surveillance, health care performance measurement and quality improvement. Data derived from clinical trials provides new knowledge for innovation, evidence based medicine and improved clinical practice guidelines all of which drives clinical laboratory testing [1].

References

1. Carlson RO., et al. “A primer on the cost of quality for improvement of laboratory and pathology specimen processes”. American Journal of Clinical Pathology 138 (2012): 347-354.
2. Elbireer A., et al. “Cost of quality at a clinical laboratory in a resource limited country”. Lab Medicine 41 (2010): 429-433.
3. Mario P. “The Detection and Prevention of Errors in Laboratory Medicine”. Annals of Clinical Biochemistry 47 (2010): 101-110.
4. Understanding the Cost of Quality in the Laboratory; A Report. CLSI document QMS20-R, PA: Clinical and Laboratory Standards Institute (2014).
5. Williems P and Quintenz A. “Exploring cost of quality in the laboratory”. Medical Lab Observer (2018).
6. Dawson J. Medical Laboratory Management Magazine, What's Your CoPQ? Quantifying the Value of Laboratory Quality, Medical Laboratory Management Magazine 6.6 (2017).

Citation

Citation: Ashok Rattan. “Understanding Cost of Quality in the Laboratory”. Acta Scientific Microbiology 4.11 (2021): 16-20.

Copyright

Copyright: © 2021 Ashok Rattan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.